|
mRNA_ID
|
Gene Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
nasopharyngeal carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
pilocytic astrocytoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
gallbladder cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
chondrosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
cervical cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
glioblastoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
glioblastoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
choriocarcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
gallbladder cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
malignant melanoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
liver cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
chondrosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
bone marrow mesenchymal stem cells
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
clear cell renal cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
ALDH+ lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
upper urinary urothelial carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
cervical cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
liver cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
cervical cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
cervical cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
ewing sarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
anaplastic thyroid cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
bladder cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
bladder cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
melanoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
melanoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
malignant melanoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
retinoblastoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
nasopharyngeal carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
renal cell cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
liver cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
diffuse large b cell lymphoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
glioblastoma multiforme (gbm)
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
laryngeal squamous cell cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
glioma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
glioma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
oral squamous cell cancer (oscc)
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
endometrial cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
weri-RB-1 retinoblastoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
triplenegative breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
glioma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
glioma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
melanoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
lung adenocarcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
oral squamous cell cancer (oscc)
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
neuroblastoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
renal cell cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
acute megakaryocytic leukemia
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
laryngeal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
oral tongue squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
cutaneous squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PI3K
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263967
|
PIK3CA
|
DB05098
|
Leptin
|
lung injury
|
down-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PIK3CA
|
DB00244
|
Mesalazine
|
chronic ulcerative colitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PIK3CA
|
DB00987
|
Cytarabine
|
high-grade glioma
|
down-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PIK3CA
|
NA
|
Compound musk injection
|
ischemic stroke
|
up-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PIK3CA
|
DB00762
|
Irinotecan
|
colorectal cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PIK3CA
|
NA
|
Tongluo Baoshen formula
|
diabetic kidney disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PIK3CA
|
NA
|
Mackiain
|
obesity
|
down-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PIK3CA
|
NA
|
Ononin
|
obesity
|
down-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PIK3CA
|
NA
|
Cuscuta chinensis Lam. and Lycium barbarum L.
|
asthenospermia
|
up-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PIK3CA
|
NA
|
Gualou-Xiebai-Banxia decoction
|
cardiovascular diseases
|
down-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PIK3CA
|
DB15588
|
Ursolic acid
|
aortic aneurysm
|
down-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PIK3CA
|
NA
|
Effective-component compatibility of Bufei Yishen formula I
|
chronic obstructive pulmonary disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PI3K
|
DB14981
|
Fytic acid (Inositol hexaphosphate)
|
colorectal cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PI3K
|
DB04865
|
Omacetaxine mepesuccinate (homoharringtonine)
|
colon cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000263967
|
PI3K
|
DB02640 (EXPT01509)
|
Fumagillin
|
cancer
|
down-regulated
|
validated
|
more...
|